Bio-Rad Laboratories, Inc. (NYSE:BIO)
CAPS Rating:
The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.
RSS Headlines
Fool UK
Recs
Cut in earnings leaves the stock worth $50-60. This one still has further to fall.